W.R. Berkley’s DA32 Life Science Tech Acquisition Corp DALS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-157,016
Closed -$1.52M – 540
2022
Q2
$1.52M Hold
157,016
– – 0.08% 262
2022
Q1
$1.52M Hold
157,016
– – 0.08% 265
2021
Q4
$1.54M Hold
157,016
– – 0.09% 268
2021
Q3
$1.54M Buy
+157,016
New +$1.55M 0.1% 186

Other funds holding DALS

W.R. Berkley's DALS Position: Q3 2022 in Review

W.R. Berkley sold out of DA32 Life Science Tech Acquisition Corp (DALS) in Q3 2022, closing a stake of 157,016 shares — an estimated $1.52M sold.

W.R. Berkley first reported a position in DALS in Q3 2021 and held it in 4 quarters. The position peaked at $1.54M in Q3 2021. 43 funds tracked by Wall St. Rank hold DALS as of Q3 2022.

  • W.R. Berkley reported no remaining DA32 Life Science Tech Acquisition Corp position as of Q3 2022 after selling out during the quarter.
  • W.R. Berkley sold 157,016 DA32 Life Science Tech Acquisition Corp shares in Q3 2022, an estimated $1.52M.
  • W.R. Berkley first reported a position in DA32 Life Science Tech Acquisition Corp in Q3 2021 and held it in 4 quarters.
  • W.R. Berkley's DA32 Life Science Tech Acquisition Corp position peaked at $1.54M in Q3 2021.
  • 43 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp as of Q3 2022.

Based on W.R. Berkley's 13F filing for Q3 2022, filed 14 Nov 2022.